May is the month for esophageal, intestinal and gastric health – How to prevent diseases and diagnose them early?

May is devoted to increase the awareness of digestive diseases and their prevention. Colorectal cancer is one of the most common types of cancer among the Finnish people. Biohit Oyj and UEG (United European Gastroenterology) encourage to prevention of these cancers by testing the intestinal and gastric health and by paying attention to a healthy lifestyle.

Read more

Constitutive meeting of Biohit Oyj’s Board of Directors

Biohit Oyj’s Board of Directors has in its meeting yesterday elected Mr Osmo Suovaniemi as the Chairman of the Board of Directors.

Read more

Decisions of the Annual General Meeting of Biohit Oyj

The Annual General Meeting (AGM) of Biohit Oyj held on Wednesday April 24, 2019 approved the financial statements of the parent company and the consolidated financial statements, and discharged the members of the Board of Directors and the President and CEO from liability for the financial year 2018.

Read more

Acetium® lozenge for smoking intervention will shortly be distributed in Italy within Difar Consumer Care® product division

Read more

Acetium® lozenge for smoking intervention will be available in Thailand during the year 2019

Biohit Oyj and Precision Health Co., Ltd have signed an agreement for the distribution of the Acetium lozenge in Thailand.

Read more

Biohit GastroPanel® biomarkers validated as powerful predictors of gastric cancer risk in a multicenter study

Biohit GastroPanel® innovation is the unique non-invasive diagnostic tool for examination of i) dyspeptic patients for exclusion or diagnosis of Helicobacter pylori (Hp) infection and atrophic gastritis (AG), also disclosing the functional status of gastric acid output, as well as ii) for screening of asymptomatic individuals for the risk of gastric cancer (GC) …

Read more

Satya Abadi Pharma to distribute Acetium® lozenge in Indonesia

Biohit Oyj and Satya Abadi Pharma have signed an agreement for the distribution of the Acetium lozenge in Indonesia. The effectiveness of…

read more

Notice of Biohit Oyj’s Annual General Meeting

Notice of Biohit Oyj’s Annual General Meeting Biohit Oyj Stock Exchange Release March 29, 2019 at 9:30 am local time (EEST) Biohit Oyj shareholders are invited to attend the company’s…

Read more

Publication of Biohit Oyj Annual Report 2018

Biohit Oyj Annual Financial Report March 29, 2018 at 9:30 am local time (EET)   Biohit Oyj’s Annual Report 2018 is published today in PDF format. The annual report contains financial…

Read more

Finns choose a domestic nicotine-free product as their preferred smoking intervention method

Biohit Oyj and Sanoma Media invited 40 volunteers to try and quit smoking by using Acetium® lozenge and asked for feedback on their experience of using this alternative method. They received encouraging and positive comments from the users and with the help of Acetium, 93% of the test group reduced smoking significantly or quit smoking completely during the two months of testing.

Read more